Physician profile
John M Miles
NPI 1164494233
$12,807.10
in general payments reported to CMS, 2019-2025
19 companies · $217 in 2025
The $217 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,742 · 2020: $2,528 · 2021: $2,376 · 2022: $533 · 2023: $262 · 2024: $148 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $5,123.91 | 2019-2025 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $3,341.76 | 2019-2023 | |
| Roche Diabetes Care Gmbh | $1,875.00 | 2019 | |
| Baxter Healthcare | $1,508.08 | 2019 | |
| Lilly USA, LLC | $284.11 | 2019-2025 | Zepbound |
| Xeris Pharmaceuticals, INC. | $211.31 | 2022-2023 | Gvoke Hypopen |
| Fresenius Kabi USA, LLC | $108.58 | 2024 | Smoflipid |
| Alcresta Therapeutics, INC. | $90.46 | 2022 | |
| Amarin Pharma, INC. | $59.25 | 2019 | |
| Esperion Therapeutics, INC. | $51.71 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $24.65 | 2021 | |
| Amneal Pharmaceuticals LLC | $19.19 | 2025 | Unithroid |
| Janssen Scientific Affairs, LLC | $18.37 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.17 | 2021 | |
| Merck Sharp & Dohme LLC | $16.85 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15.17 | 2024 | Minimed 780g |
| Beta Bionics, INC. | $15.12 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Abbott Laboratories | $13.07 | 2021 | |
| Antares Pharma, INC. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.